Stock Taper
SCREENER COMPARE ANY 2 STOCKS
RLYB
RALLYBIO CORPORATION
NASDAQ
$16.88
▲ UP 0.75% (0.13)

KEY STATISTICS

Market Cap$88.89 M
52w High$17.57
52w Low$3.67
Dividend Yield—
Frequency—
P/E-4.44
Volume6.54K
Shares Out.5.31M

COMPANY

LEADERSHIP

Stephen Uden
CHIEF EXECUTIVE
Stephen Uden

COMPENSATION 2026

Salary$551,200
Stock Awards$0
Incentive Plan Pay$248,040
All Other Comp.$13,800
Total$1,127,666

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 29, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
7

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.—
NOV
5
THU

SPLIT RECORD

DATETYPERATIO
2026-02-06Reverse1:8

PRICE

$16.88 ▲ UP 0.75% (+$0.13)
OVERLAYS
$16.65$16.80$16.959:35 AM10:39 AM11:43 AM12:47 PM1:51 PM2:55 PM3:59 PM16.88

About Rallybio Corporation

https://www.rallybio.com ↗

Rallybio is a clinical-stage biotech developing therapies for rare diseases, including monoclonal antibodies and complement inhibitors, with collaborations with AbCellera, Exscientia, and J&J.

INDUSTRY

Biotechnology

A PRODUCT RALLYBIO CORPORATION IS KNOWN FOR

RLYB116
RLYB116

RLYB116 is a C5 inhibitor developed by Rallybio to treat complement dysregulation diseases, now their leading and most advanced therapy after discontinuing their previous candidate.

COMPETITORS

COMPETITOR
ALNY COMPARE
AZN COMPARE
BBIO COMPARE
BMRN COMPARE
QURE COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q3-2025Q4-2025Q1-2026
Collaboration And License Revenue$212K $212K $222K ▲$212K ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
17
LISTED HERE
4
RANKED BY POSITION SIZE
VTI
0.00% · 134.6K
IWC
0.01% · 11.8K
DFAS
0.00% · 6.7K
AVSC
0.00% · 1.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
62
TOP 12 OF 62 · RANKED BY POSITION SIZE
Viking Global Investors LP
4.2M sh · $2.88M
Johnson & Johnson
3.6M sh · $2.49M
5am Venture Management, LLC
3.6M sh · $2.49M
New Leaf Venture Partners, L.L.C.
3.3M sh · $1.65M
Tpg Gp A, LLC
3.0M sh · $2.09M
Tpg Group Holdings (Sbs) Advisors, Inc.
3.0M sh · $53.24M
Pivotal Bioventure Partners Investment Advisor LLC
2.4M sh · $1.2M
Tekla Capital Management LLC
1.7M sh · $9.78M
Fmr LLC
1.7M sh · $845.5K
Almitas Capital LLC
1.5M sh · $767.83K
Vanguard Group Inc
1.0M sh · $697.15K
Renaissance Technologies LLC
835.7K sh · $573.37K

RATINGS SNAPSHOT

Overall rating: A-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings3
Price To Book4
Overall Score4

INSIDER TRADES

★
DIRECTOR
Boudreau Helen M
Purchase · 3.6K shares
2026-07-06
★
DIRECTOR
Boudreau Helen M
Sale · 3.6K shares
2026-07-06
★
10 PERCENT OWNER
ADAR1 Capital Management, LLC
Purchase · 200 shares
2026-05-19
★
10 PERCENT OWNER
ADAR1 Capital Management, LLC
Purchase · 10.0K shares
2026-05-19

SECTORS PEERS

PEERPRICE
QTTB$10.94COMPARE
BOLD$2.85COMPARE
TAOX$3.93COMPARE
IBIO$1.23COMPARE
INTS$3.98COMPARE
XCUR$1.34COMPARE
CVKD$1.13COMPARE